PSI CRO Continues Asia-Pacific Growth, Expands into New Office in Bangkok 

PSI CRO, 7 May 2024PSI CRO is continuing to expand its clinical research operations in the Asia-Pacific region with the opening of a new office in Bangkok, Thailand, at Park Silom, Unit 1407-1408, 1 Convent Road, Silom Bang Rak. The new Thailand location will add to PSI’s expansion in the region, further supporting the on-time delivery of clinical trials through local relationships and broadened operational capabilities. 

In Asia, PSI is already fully operational with a long-standing presence in South Korea, China, Hong-Kong, Taiwan, Singapore, Australia and New Zealand.  Barrie Koh, PSI Head of Asia Pacific, said, “Operational Expansion to Thailand marks a significant milestone for us, reinforcing our continued growth across Asia Pacific. The strategic location of our new office underscores our commitment to serving our clients with excellence, achieving reliable and predictable patient enrollment across the region. Every Patient Counts has been our mantra across PSI globally; here in Thailand it resonates with a great deal of significance and meaning. We are excited to add another high-enrolling country to PSI’s portfolio.” 

The new office is located in the heart of the Silom Bang Rak business district. It offers outstanding connectivity with its excellent transportation options, ensuring convenient access for employees. Additionally, the office space can accommodate a growing team of both operational and clinical local staff, allowing PSI teams to maintain a strong local presence and relationships with the clinical sites in the region.  

With a uniquely modern look and feel, the atmosphere of PSI’s Bangkok office is a testament to the distinctive dedication and partnership that PSI provides for employees and clinical trial sponsors alike. The team celebrated the official opening on April 4 with a ribbon-cutting ceremony and blessing performed by Buddhist monks. 

“Our team is dedicated to delivering exceptional service and solutions, and we are confident that our presence at Park Silom will enable PSI to better meet the evolving needs of our clients,” says Koh. “We extend our gratitude to our employees, sites, and clients for their continued support!” 

About PSI: PSI CRO is a privately-owned, full-service clinical research organization (CRO) operating globally. PSI’s global reach supports clinical trials across multiple countries and continents and specializes in the planning and execution of global pivotal registration clinical trials. With an exceptionally high repeat and referral business rate combined with minimal staff turnover, PSI is committed to being the best CRO in the world as measured by its employees, customers, investigators, and vendors. 

Global headquarters are located in Switzerland at 113a Baarerstrasse, Zug 6300. 

For Media Inquiries: 

Ashley Collins, Marketing Specialist 919-972-9572 |